Analyst Ratings for Halozyme Therapeutics (halo)
halo Rating Summary
halo Price Target Summary
- Highest: $59.00 (Morgan Stanley)
- Lowest: $40.00 (Goldman Sachs)
- Average: $49.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.57 (+28.1%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
Avg. $ Target:
$49.57 (+28.1%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/29/2024 | TD Cowen | Brendan Smith | New Coverage | Buy (N/A) |
54.00 (N/A) |
39.69 (38.71) |
-2.47% | Details |
| 7/24/2023 | H.C. Wainwright » Updated 2/21/2024 |
Mitchell Kapoor | New Coverage | Buy (N/A) |
50.00 (48.00) |
42.89 (38.71) |
-9.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
